Kathie Bishop | executive |
Albert Kildani | executive |
Stephen Davis | executive |
Brendan Teehan | executive |
Doug Williamson | executive |
Mark Schneyer | executive |
Ritu Baral | analyst |
Tessa Romero | analyst |
Yatin Suneja | analyst |
Gregory Renza | analyst |
Parag Meswani | executive |
Lee Hung | analyst |
Charles Duncan | analyst |
Ashwani Verma | analyst |
Tazeen Ahmad | analyst |
Uy Ear | analyst |
Madhumita Yennawar | analyst |
Sumant Kulkarni | analyst |
Ami Fadia | analyst |
Jay Olson | analyst |
Good day, ladies and gentlemen, and welcome to Acadia Pharmaceutical's Third Quarter 2023 Financial Results Conference Call. My name is Kathie, and I will be your coordinator for today. [Operator Instructions]I would now like to turn the presentation over to Al Kildani, Senior Vice President of Investor Relations and Corporate Communications at Acadia. Please proceed.
Thank you, Kathie.